Search clinical trials for: Mutaflor® Suspension

Total 14706 results

Hospital San Bartolome
Instituto de Investigacion de las Alteraciones del Crecimiento, Desarrollo...

Unknown

Prophylaxis of Gastrointestinal Infections With EcN (PIURA)

Infantile Diarrhea

Peru
University of Hohenheim
Ardeypharm GmbH

Completed

E. Coli Nissle in Oncology (EcNO)

Gastric Cancer | Colorectal Cancer

Germany
University of Zurich

Unknown

Effects of Nutritional Fat on the Growth of Intestinal E. Coli

Escherichia Coli Infections

Switzerland
Keimyung University Dongsan Medical Center

Completed

The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study

Constipation

Korea, Republic of
Charite University, Berlin, Germany

Completed

Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen Rhinoconjunctivitis (Ecorhino)

Rhinoconjunctivitis

Germany
Nationwide Children's Hospital
Thrasher Research Fund

Completed

Novel Probiotic Treatment for Prevention of Recurrent UTIs in Children (Nissle 1917)

Catheter-Related Infections | Recurrent UTIs

United States
Elizabeth Lucas

Completed

Open Label Trial of Nissle 1917

Urinary Tract Infections

United States
Kangbuk Samsung Hospital

Completed

Additive Effect of Probiotics (Mutaflor®) in Patients With Ulcerative Colitis on 5-ASA Treatment.

Ulcerative Colitis

Korea, Republic of
Glock Health, Science and Research GmbH

Completed

G-PUR® for Reduced Lead Bioavailability

Lead Exposure

Austria
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease

Coronary Artery Disease

United States
Point Biomedical

Completed

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

Coronary Artery Disease

United States
Point Biomedical

Terminated

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent for Diagnosis of Coronary Artery Disease (POINT II)

Coronary Artery Disease

United States
Point Biomedical

Completed

Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease

Coronary Artery Disease | Healthy

United States
NICHD Pelvic Floor Disorders Network
Boston Scientific Corporation

Active, not recruiting

Study of Uterine Prolapse Procedures - Randomized Trial (SUPeR)

Uterovaginal Prolapse

United States
Point Biomedical

Completed

Safety and Efficacy Study of PB127 Ultrasound Contrast Agent in Patients With Suspected Coronary Artery Disease 007

Coronary Artery Disease

United States
Point Biomedical

Terminated

Evaluation and Optimization of PB127 Myocardial Perfusion Echocardiography on Ultrasound Systems

Coronary Artery Disease | Healthy

United States
GWT-TUD GmbH
Ardeypharm GmbH

Completed

Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II (PUNiDIA)

Diabetes Mellitus Type II

Germany
Lantheus Medical Imaging

Completed

A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY® in Clinical Practice

Cardiovascular Disease

United States
Lantheus Medical Imaging

Completed

DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function

Ventricular Ejection Fraction

United States
Alcon Research

Completed

6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Glaucoma
University of Copenhagen

Unknown

Probiotics in the Treatment of Irritable Bowel Syndrome

Irritable Bowel Syndrome

Norway
Karadeniz Technical University

Completed

Effects of Probiotics on Neonatal Hyperbilirubinemia

Neonatal Hyperbilirubinemia
GlaxoSmithKline

Completed

Amoxicillin Bioequivalence Study Brazil - Fast

Infections, Bacterial

Brazil
LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

United States
NYU Langone Health

Completed

The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants

Dysphagia

United States
University of Oulu
Turku University Hospital; Helsinki University Central Hospital; Kuopio University... and other collaborators

Recruiting

Preventing Urinary Tract Infections With E. Coli Nissle: (FinNissle)

Urinary Tract Infections in Children | Secondary Prevention

Finland
NYU Langone Health

Completed

Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates

Respiratory Aspiration | Deglutition Disorders | Respiratory Distress Syndrome In Premature Infants | Newborn, Premature
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

Healthy

United States
Baskent University
Hacettepe University

Completed

Effects of Pin and Vacuum Assisted Suspension Systems

Prosthesis User | Artificial Limbs | Amputees

Turkey
Minia University

Completed

Suspension of Falciform Ligament During Mini Gastric Bypass

Upper GIT Surgery

Egypt
LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

Canada, United Kingdom, France
GlaxoSmithKline

Completed

Bioequivalence Study of Cephalexin Suspension 125

Infections, Respiratory Tract
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Fasting

Healthy

United States
Avita Medical
Biomedical Advanced Research and Development Authority

Terminated

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Burns

United States
Pfizer

Completed

A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

Falciparum Malaria

India
GlaxoSmithKline

Completed

Bioequivalence Study of Cephalexin Suspension 250

Infections, Respiratory Tract
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions

Healthy

Canada
Actavis Inc.

Completed

A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions

Healthy

Canada
Aziende Chimiche Riunite Angelini Francesco S.p.A
Cross S.A.

Completed

New Paediatric Formulation of Tachipirina®

Healthy

Switzerland
VA Office of Research and Development
Rutgers University; University of Rhode Island

Recruiting

Quantifying Bone and Skin Movement in the Residual Limb of Individuals With Transtibial Amputation Using Dynamic Stereo X-Ray

Amputation, Lower Limb

United States
Chiesi Farmaceutici S.p.A.

Completed

Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients (STEADY)

End Stage Renal Disease

Italy
Siesta Medical, Inc.

Terminated

FAST as a Treatment for Obstructive Sleep Apnea (FAST)

Obstructive Sleep Apnea

United States
Ferring Pharmaceuticals

Recruiting

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
The Methodist Hospital Research Institute

Unknown

Intraperitoneal and Extraperitoneal Uterosacral Ligament Suspensions for Post-Hysterectomy Vaginal Vault Prolapse

Vaginal Vault Prolapse | Post-Hysterectomy Vaginal Vault Prolapse | Prolapse, Vaginal

United States
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men

Coronary Artery Disease

United States
ERYtech Pharma

No longer available

Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase (EAP)

Acute Lymphoblastic Leukemia

France
Galapagos NV

Completed

First-in-Human Single and Multiple Dose of GLPG1205

Healthy

Belgium

3

Subscribe